UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 526.6 EUR Market Closed

Market Cap: €14.9B

U	United Therapeutics Corp XMUN:UTH	US
	Industrias Penoles SAB de CV OTC:IPOAF	MX
	Pirelli and C. S.p.a MIL:PIRC	IT
E	Erlebnis Akademie AG XMUN:EAD	DE
	Utah Medical Products Inc F:UTM	US
U	United Therapeutics Corp F:UTH	US
S	Siemens AG DUS:SIE	DE
B	Blu Label Unlimited Group Ltd XMUN:5TP	ZA
	CanAlaska Uranium Ltd F:DH7	CA

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

88%

Declining Gross Margin

89% > 86%

Exceptional Operating Margin

44%

Strong 3Y Average Operating Margin

48%

Declining Operating Margin

50% > 44%

Exceptional Net Margin

42%

Strong 3Y Average Net Margin

41%

Net Margin is Increasing

41% > 42%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

35% > 34%

Positive ROE

19%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

29%

ROIC is Increasing

26% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.